Labcorp will acquire multiple same-day testing labs and select technical assets from Incyte, including its main anatomic pathology lab in Spokane, Washington.

Last week, readers were most interested in a story about Mursla's liver cancer test for detecting microRNA and protein targets within extracellular vesicles.

NEW YORK – Eight German associations are calling for changes to be made to the European In Vitro Diagnostics Regulation (IVDR ...

NEW YORK — Octave Bioscience said Tuesday that its Multiple Sclerosis Disease Activity (MSDA) test has received certification from the New York State Clinical Laboratory Evaluation Program. The test ...

NEW YORK – Diagnostic companies saw their stock prices continue to decline in April, falling 4 percent after a 5 percent decline in March, and dipping even deeper than the broader market. The Top 30 ...

The former True Health Diagnostics executives were accused of participating in a scheme that paid Texas physicians for blood test referrals.

NEW YORK – With its combination immunoassay and qPCR blood test, Mursla Bio intends to identify liver cancers earlier by detecting microRNA and protein targets within extracellular vesicles. Last week ...

NEW YORK – Uppsala University spinout Readily Diagnostics is using technology built off 30 years of research as the basis of a point-of-care, instrument-free test that would detect and differentiate ...

NEW YORK – Hologic reported after the close of the market on Thursday that its fiscal second quarter diagnostics revenues rose 1 percent year over year on growth in the company's molecular diagnostics ...